{"entity":{"type":"insider","cik":"0001372932","url":"/insider/0001372932","json_url":"/insider/0001372932.json","name":"DP VII ASSOCIATES LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":69,"n_filings":42,"first":"2008-12-11","last":"2016-05-27","span_basis":"filed_date"},"name_variants":[{"name":"DP VII ASSOCIATES LP","source":"filing","n_filings":42,"first_seen":"2008-12-11","last_seen":"2016-05-27"}],"transactions":[{"id":3069945,"accession":"0000904454-16-001237","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001237","line_url":"/filing/0000904454-16-001237#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; DP VII ASSOCIATES LP; Halak Brian K; TREU JESSE I; VITULLO NICOLE; BLAIR JAMES C","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5880.0,"shares_display":"5,880","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":27636.0,"total_display":"27,636.00","total_whole":"27,636","shares_owned_after":10328.0,"shares_owned_after_display":"10,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-26","filed_date":"2016-05-27","scope":"insider"},{"id":2311064,"accession":"0000904454-16-001190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001190","line_url":"/filing/0000904454-16-001190#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; VITULLO NICOLE; DP VII ASSOCIATES LP; DOVEY BRIAN H; Halak Brian K","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61.0,"shares_display":"61","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":306.22,"total_display":"306.22","total_whole":"306","shares_owned_after":16208.0,"shares_owned_after_display":"16,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-27","filed_date":"2016-04-27","scope":"insider"},{"id":2311058,"accession":"0000904454-16-001190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001190","line_url":"/filing/0000904454-16-001190#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; VITULLO NICOLE; DP VII ASSOCIATES LP; DOVEY BRIAN H; Halak Brian K","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21.0,"shares_display":"21","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":109.2,"total_display":"109.20","total_whole":"109","shares_owned_after":16269.0,"shares_owned_after_display":"16,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-25","filed_date":"2016-04-27","scope":"insider"},{"id":2361943,"accession":"0000904454-16-001172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001172","line_url":"/filing/0000904454-16-001172#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VII ASSOCIATES LP; DOVEY BRIAN H; TREU JESSE I; Halak Brian K; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76.0,"shares_display":"76","price_per_share":5.29,"price_display":"5.29","price_state":"stated","total_value":402.04,"total_display":"402.04","total_whole":"402","shares_owned_after":16290.0,"shares_owned_after_display":"16,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-21","scope":"insider"},{"id":2361937,"accession":"0000904454-16-001172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001172","line_url":"/filing/0000904454-16-001172#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VII ASSOCIATES LP; DOVEY BRIAN H; TREU JESSE I; Halak Brian K; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":632.0,"shares_display":"632","price_per_share":5.36,"price_display":"5.36","price_state":"stated","total_value":3387.52,"total_display":"3,387.52","total_whole":"3,388","shares_owned_after":16366.0,"shares_owned_after_display":"16,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-19","filed_date":"2016-04-21","scope":"insider"},{"id":2311044,"accession":"0000904454-16-001166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001166","line_url":"/filing/0000904454-16-001166#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; DP VII ASSOCIATES LP","owner_display_name":"Halak Brian K","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75.0,"shares_display":"75","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":391.5,"total_display":"391.50","total_whole":"392","shares_owned_after":16998.0,"shares_owned_after_display":"16,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-11","filed_date":"2016-04-13","scope":"insider"},{"id":2773146,"accession":"0000904454-16-001156","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-16-001156","line_url":"/filing/0000904454-16-001156#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; DOVEY BRIAN H; DP VII ASSOCIATES LP; BLAIR JAMES C; Halak Brian K","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":251.0,"shares_display":"251","price_per_share":5.35,"price_display":"5.35","price_state":"stated","total_value":1342.85,"total_display":"1,342.85","total_whole":"1,343","shares_owned_after":17073.0,"shares_owned_after_display":"17,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-08","filed_date":"2016-04-08","scope":"insider"},{"id":2773139,"accession":"0000904454-16-001156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001156","line_url":"/filing/0000904454-16-001156#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; DOVEY BRIAN H; DP VII ASSOCIATES LP; BLAIR JAMES C; Halak Brian K","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":475.0,"shares_display":"475","price_per_share":5.26,"price_display":"5.26","price_state":"stated","total_value":2498.5,"total_display":"2,498.50","total_whole":"2,499","shares_owned_after":17324.0,"shares_owned_after_display":"17,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-07","filed_date":"2016-04-08","scope":"insider"},{"id":2773125,"accession":"0000904454-16-001156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001156","line_url":"/filing/0000904454-16-001156#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; DOVEY BRIAN H; DP VII ASSOCIATES LP; BLAIR JAMES C; Halak Brian K","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148.0,"shares_display":"148","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":772.56,"total_display":"772.56","total_whole":"773","shares_owned_after":17799.0,"shares_owned_after_display":"17,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-06","filed_date":"2016-04-08","scope":"insider"},{"id":8778943,"accession":"0000904454-15-000538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-15-000538","line_url":"/filing/0000904454-15-000538#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; DP VII ASSOCIATES LP; VITULLO NICOLE; BLAIR JAMES C; Halak Brian K; TREU JESSE I; SCHOEMAKER KATHLEEN K","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":202.0,"shares_display":"202","price_per_share":7.02,"price_display":"7.02","price_state":"stated","total_value":1418.04,"total_display":"1,418.04","total_whole":"1,418","shares_owned_after":17947.0,"shares_owned_after_display":"17,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-20","scope":"insider"},{"id":8125635,"accession":"0000904454-15-000244","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-15-000244","line_url":"/filing/0000904454-15-000244#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VII ASSOCIATES LP; Halak Brian K; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_display_name":"DP VII ASSOCIATES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":554.0,"shares_display":"554","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":3916.78,"total_display":"3,916.78","total_whole":"3,917","shares_owned_after":18149.0,"shares_owned_after_display":"18,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-16","filed_date":"2015-04-16","scope":"insider"},{"id":8125631,"accession":"0000904454-15-000244","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-15-000244","line_url":"/filing/0000904454-15-000244#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VII ASSOCIATES LP; Halak Brian K; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_display_name":"DP VII ASSOCIATES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135.0,"shares_display":"135","price_per_share":7.58,"price_display":"7.58","price_state":"stated","total_value":1023.3,"total_display":"1,023.30","total_whole":"1,023","shares_owned_after":18703.0,"shares_owned_after_display":"18,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-15","filed_date":"2015-04-16","scope":"insider"},{"id":8125626,"accession":"0000904454-15-000244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-15-000244","line_url":"/filing/0000904454-15-000244#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VII ASSOCIATES LP; Halak Brian K; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_display_name":"DP VII ASSOCIATES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":168.0,"shares_display":"168","price_per_share":7.78,"price_display":"7.78","price_state":"stated","total_value":1307.04,"total_display":"1,307.04","total_whole":"1,307","shares_owned_after":18838.0,"shares_owned_after_display":"18,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-14","filed_date":"2015-04-16","scope":"insider"},{"id":5048529,"accession":"0000904454-13-000770","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000770","line_url":"/filing/0000904454-13-000770#line-2","is_derivative":false,"issuer_cik":"0001372932","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001372932","owner_cik":"0001372932","owner_name":"DP VII ASSOCIATES LP","owner_display_name":"DP VII ASSOCIATES LP","owner_url":"/insider/0001372932","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4791.0,"shares_display":"4,791","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":67074.0,"total_display":"67,074.00","total_whole":"67,074","shares_owned_after":35253.0,"shares_owned_after_display":"35,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-01","filed_date":"2013-07-02","scope":"insider"},{"id":4573005,"accession":"0000904454-13-000663","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000663","line_url":"/filing/0000904454-13-000663#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; DP VII ASSOCIATES LP","owner_display_name":"Halak Brian K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2779.0,"shares_display":"2,779","price_per_share":64.58,"price_display":"64.58","price_state":"stated","total_value":179467.82,"total_display":"179,467.82","total_whole":"179,468","shares_owned_after":44034.0,"shares_owned_after_display":"44,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-04","filed_date":"2013-06-05","scope":"insider"},{"id":4620271,"accession":"0000904454-13-000467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000467","line_url":"/filing/0000904454-13-000467#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; BLAIR JAMES C; VITULLO NICOLE; Halak Brian K; TREU JESSE I; DP VII ASSOCIATES LP; DOVEY BRIAN H","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":893.0,"shares_display":"893","price_per_share":5.49,"price_display":"5.49","price_state":"stated","total_value":4902.57,"total_display":"4,902.57","total_whole":"4,903","shares_owned_after":40484.0,"shares_owned_after_display":"40,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-21","filed_date":"2013-03-22","scope":"insider"},{"id":4853694,"accession":"0000904454-13-000459","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000459","line_url":"/filing/0000904454-13-000459#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; Halak Brian K; DOVEY BRIAN H; DP VII ASSOCIATES LP; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92.0,"shares_display":"92","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":480.24,"total_display":"480.24","total_whole":"480","shares_owned_after":41377.0,"shares_owned_after_display":"41,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-20","filed_date":"2013-03-21","scope":"insider"},{"id":4853689,"accession":"0000904454-13-000459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000459","line_url":"/filing/0000904454-13-000459#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; Halak Brian K; DOVEY BRIAN H; DP VII ASSOCIATES LP; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":134.0,"shares_display":"134","price_per_share":5.19,"price_display":"5.19","price_state":"stated","total_value":695.46,"total_display":"695.46","total_whole":"695","shares_owned_after":41469.0,"shares_owned_after_display":"41,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-19","filed_date":"2013-03-21","scope":"insider"},{"id":5494877,"accession":"0000904454-13-000449","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000449","line_url":"/filing/0000904454-13-000449#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; BLAIR JAMES C; VITULLO NICOLE; Halak Brian K; TREU JESSE I; DP VII ASSOCIATES LP; DOVEY BRIAN H","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135.0,"shares_display":"135","price_per_share":5.16,"price_display":"5.16","price_state":"stated","total_value":696.6,"total_display":"696.60","total_whole":"697","shares_owned_after":41603.0,"shares_owned_after_display":"41,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-18","filed_date":"2013-03-19","scope":"insider"},{"id":5494874,"accession":"0000904454-13-000449","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000449","line_url":"/filing/0000904454-13-000449#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; BLAIR JAMES C; VITULLO NICOLE; Halak Brian K; TREU JESSE I; DP VII ASSOCIATES LP; DOVEY BRIAN H","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":163.0,"shares_display":"163","price_per_share":5.28,"price_display":"5.28","price_state":"stated","total_value":860.64,"total_display":"860.64","total_whole":"861","shares_owned_after":41738.0,"shares_owned_after_display":"41,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-15","filed_date":"2013-03-19","scope":"insider"},{"id":4217052,"accession":"0000904454-13-000439","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000439","line_url":"/filing/0000904454-13-000439#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Halak Brian K; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; DP VII ASSOCIATES LP; BLAIR JAMES C; TREU JESSE I","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85.0,"shares_display":"85","price_per_share":5.36,"price_display":"5.36","price_state":"stated","total_value":455.6,"total_display":"455.60","total_whole":"456","shares_owned_after":41901.0,"shares_owned_after_display":"41,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-14","filed_date":"2013-03-15","scope":"insider"},{"id":4217048,"accession":"0000904454-13-000439","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000439","line_url":"/filing/0000904454-13-000439#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Halak Brian K; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; DP VII ASSOCIATES LP; BLAIR JAMES C; TREU JESSE I","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131.0,"shares_display":"131","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":707.4,"total_display":"707.40","total_whole":"707","shares_owned_after":41986.0,"shares_owned_after_display":"41,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-13","filed_date":"2013-03-15","scope":"insider"},{"id":5435113,"accession":"0000904454-13-000431","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000431","line_url":"/filing/0000904454-13-000431#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; DP VII ASSOCIATES LP; VITULLO NICOLE; BLAIR JAMES C; Halak Brian K; DOVEY BRIAN H","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107.0,"shares_display":"107","price_per_share":5.38,"price_display":"5.38","price_state":"stated","total_value":575.66,"total_display":"575.66","total_whole":"576","shares_owned_after":42117.0,"shares_owned_after_display":"42,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-12","filed_date":"2013-03-13","scope":"insider"},{"id":5435110,"accession":"0000904454-13-000431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000431","line_url":"/filing/0000904454-13-000431#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; DP VII ASSOCIATES LP; VITULLO NICOLE; BLAIR JAMES C; Halak Brian K; DOVEY BRIAN H","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70.0,"shares_display":"70","price_per_share":5.34,"price_display":"5.34","price_state":"stated","total_value":373.8,"total_display":"373.80","total_whole":"374","shares_owned_after":42224.0,"shares_owned_after_display":"42,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-11","filed_date":"2013-03-13","scope":"insider"},{"id":5494871,"accession":"0000904454-13-000403","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000403","line_url":"/filing/0000904454-13-000403#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I; BLAIR JAMES C; Halak Brian K; DOVEY BRIAN H; DP VII ASSOCIATES LP","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88.0,"shares_display":"88","price_per_share":5.32,"price_display":"5.32","price_state":"stated","total_value":468.16,"total_display":"468.16","total_whole":"468","shares_owned_after":42294.0,"shares_owned_after_display":"42,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-08","filed_date":"2013-03-11","scope":"insider"},{"id":5494867,"accession":"0000904454-13-000403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000403","line_url":"/filing/0000904454-13-000403#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I; BLAIR JAMES C; Halak Brian K; DOVEY BRIAN H; DP VII ASSOCIATES LP","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":215.0,"shares_display":"215","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":1122.3,"total_display":"1,122.30","total_whole":"1,122","shares_owned_after":42382.0,"shares_owned_after_display":"42,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-07","filed_date":"2013-03-11","scope":"insider"},{"id":4431080,"accession":"0000904454-13-000391","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000391","line_url":"/filing/0000904454-13-000391#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; DP VII ASSOCIATES LP; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; Halak Brian K; DOVEY BRIAN H","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65.0,"shares_display":"65","price_per_share":5.06,"price_display":"5.06","price_state":"stated","total_value":328.9,"total_display":"328.90","total_whole":"329","shares_owned_after":42597.0,"shares_owned_after_display":"42,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-06","filed_date":"2013-03-07","scope":"insider"},{"id":4431069,"accession":"0000904454-13-000386","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-13-000386","line_url":"/filing/0000904454-13-000386#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; DOVEY BRIAN H; VITULLO NICOLE; BLAIR JAMES C; DP VII ASSOCIATES LP; SCHOEMAKER KATHLEEN K; TREU JESSE I","owner_display_name":"Halak Brian K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1651.0,"shares_display":"1,651","price_per_share":24.51,"price_display":"24.51","price_state":"stated","total_value":40466.01,"total_display":"40,466.01","total_whole":"40,466","shares_owned_after":46813.0,"shares_owned_after_display":"46,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-06","filed_date":"2013-03-06","scope":"insider"},{"id":4431074,"accession":"0000904454-13-000391","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000391","line_url":"/filing/0000904454-13-000391#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; DP VII ASSOCIATES LP; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; Halak Brian K; DOVEY BRIAN H","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69.0,"shares_display":"69","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":345.69,"total_display":"345.69","total_whole":"346","shares_owned_after":42662.0,"shares_owned_after_display":"42,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-05","filed_date":"2013-03-07","scope":"insider"},{"id":4431063,"accession":"0000904454-13-000386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000386","line_url":"/filing/0000904454-13-000386#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; DOVEY BRIAN H; VITULLO NICOLE; BLAIR JAMES C; DP VII ASSOCIATES LP; SCHOEMAKER KATHLEEN K; TREU JESSE I","owner_display_name":"Halak Brian K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2132.0,"shares_display":"2,132","price_per_share":24.69,"price_display":"24.69","price_state":"stated","total_value":52639.08,"total_display":"52,639.08","total_whole":"52,639","shares_owned_after":48464.0,"shares_owned_after_display":"48,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-05","filed_date":"2013-03-06","scope":"insider"},{"id":4902313,"accession":"0000904454-13-000380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000380","line_url":"/filing/0000904454-13-000380#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I; DP VII ASSOCIATES LP; DOVEY BRIAN H; BLAIR JAMES C","owner_display_name":"Halak Brian K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88.0,"shares_display":"88","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":440.88,"total_display":"440.88","total_whole":"441","shares_owned_after":42731.0,"shares_owned_after_display":"42,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-04","filed_date":"2013-03-05","scope":"insider"},{"id":4431059,"accession":"0000904454-13-000386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000386","line_url":"/filing/0000904454-13-000386#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; DOVEY BRIAN H; VITULLO NICOLE; BLAIR JAMES C; DP VII ASSOCIATES LP; SCHOEMAKER KATHLEEN K; TREU JESSE I","owner_display_name":"Halak Brian K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":24.44,"price_display":"24.44","price_state":"stated","total_value":10191.48,"total_display":"10,191.48","total_whole":"10,191","shares_owned_after":50596.0,"shares_owned_after_display":"50,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-04","filed_date":"2013-03-06","scope":"insider"},{"id":4902308,"accession":"0000904454-13-000380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000380","line_url":"/filing/0000904454-13-000380#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I; DP VII ASSOCIATES LP; DOVEY BRIAN H; BLAIR JAMES C","owner_display_name":"Halak Brian K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130.0,"shares_display":"130","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":651.3,"total_display":"651.30","total_whole":"651","shares_owned_after":42819.0,"shares_owned_after_display":"42,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-01","filed_date":"2013-03-05","scope":"insider"},{"id":5313870,"accession":"0000904454-13-000319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000319","line_url":"/filing/0000904454-13-000319#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; BLAIR JAMES C; TREU JESSE I; Halak Brian K; DP VII ASSOCIATES LP; VITULLO NICOLE","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34.0,"shares_display":"34","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":170.34,"total_display":"170.34","total_whole":"170","shares_owned_after":42949.0,"shares_owned_after_display":"42,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-20","filed_date":"2013-02-22","scope":"insider"},{"id":5402772,"accession":"0000904454-13-000313","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000313","line_url":"/filing/0000904454-13-000313#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; BLAIR JAMES C; VITULLO NICOLE; Halak Brian K; TREU JESSE I; DP VII ASSOCIATES LP; DOVEY BRIAN H","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":171.0,"shares_display":"171","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":858.42,"total_display":"858.42","total_whole":"858","shares_owned_after":42983.0,"shares_owned_after_display":"42,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-19","filed_date":"2013-02-20","scope":"insider"},{"id":5402768,"accession":"0000904454-13-000313","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000313","line_url":"/filing/0000904454-13-000313#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; BLAIR JAMES C; VITULLO NICOLE; Halak Brian K; TREU JESSE I; DP VII ASSOCIATES LP; DOVEY BRIAN H","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51.0,"shares_display":"51","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":255.0,"total_display":"255.00","total_whole":"255","shares_owned_after":43154.0,"shares_owned_after_display":"43,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-15","filed_date":"2013-02-20","scope":"insider"},{"id":5349912,"accession":"0000904454-13-000299","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000299","line_url":"/filing/0000904454-13-000299#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VII ASSOCIATES LP; VITULLO NICOLE; TREU JESSE I; Halak Brian K; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51.0,"shares_display":"51","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":255.51,"total_display":"255.51","total_whole":"256","shares_owned_after":43205.0,"shares_owned_after_display":"43,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-14","filed_date":"2013-02-15","scope":"insider"},{"id":5349907,"accession":"0000904454-13-000299","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000299","line_url":"/filing/0000904454-13-000299#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VII ASSOCIATES LP; VITULLO NICOLE; TREU JESSE I; Halak Brian K; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98.0,"shares_display":"98","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":490.0,"total_display":"490.00","total_whole":"490","shares_owned_after":43256.0,"shares_owned_after_display":"43,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-13","filed_date":"2013-02-15","scope":"insider"},{"id":5463284,"accession":"0000904454-13-000163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000163","line_url":"/filing/0000904454-13-000163#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; BLAIR JAMES C; DP VII ASSOCIATES LP; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; TREU JESSE I","owner_display_name":"Halak Brian K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":164.0,"shares_display":"164","price_per_share":4.85,"price_display":"4.85","price_state":"stated","total_value":795.4,"total_display":"795.40","total_whole":"795","shares_owned_after":43354.0,"shares_owned_after_display":"43,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-01","filed_date":"2013-02-05","scope":"insider"},{"id":5494856,"accession":"0000904454-13-000146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000146","line_url":"/filing/0000904454-13-000146#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; DP VII ASSOCIATES LP; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; Halak Brian K; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":314.0,"shares_display":"314","price_per_share":4.71,"price_display":"4.71","price_state":"stated","total_value":1478.94,"total_display":"1,478.94","total_whole":"1,479","shares_owned_after":43518.0,"shares_owned_after_display":"43,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-31","filed_date":"2013-02-01","scope":"insider"},{"id":5494850,"accession":"0000904454-13-000146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000146","line_url":"/filing/0000904454-13-000146#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; DP VII ASSOCIATES LP; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; Halak Brian K; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188.0,"shares_display":"188","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":940.0,"total_display":"940.00","total_whole":"940","shares_owned_after":43832.0,"shares_owned_after_display":"43,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-30","filed_date":"2013-02-01","scope":"insider"},{"id":4275440,"accession":"0000904454-13-000138","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000138","line_url":"/filing/0000904454-13-000138#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; SCHOEMAKER KATHLEEN K; Halak Brian K; TREU JESSE I; BLAIR JAMES C; DOVEY BRIAN H; DP VII ASSOCIATES LP","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":260.0,"shares_display":"260","price_per_share":5.27,"price_display":"5.27","price_state":"stated","total_value":1370.2,"total_display":"1,370.20","total_whole":"1,370","shares_owned_after":44020.0,"shares_owned_after_display":"44,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-29","filed_date":"2013-01-30","scope":"insider"},{"id":4275435,"accession":"0000904454-13-000138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000138","line_url":"/filing/0000904454-13-000138#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; SCHOEMAKER KATHLEEN K; Halak Brian K; TREU JESSE I; BLAIR JAMES C; DOVEY BRIAN H; DP VII ASSOCIATES LP","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":282.0,"shares_display":"282","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":1522.8,"total_display":"1,522.80","total_whole":"1,523","shares_owned_after":44280.0,"shares_owned_after_display":"44,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-28","filed_date":"2013-01-30","scope":"insider"},{"id":5552947,"accession":"0000904454-13-000128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000128","line_url":"/filing/0000904454-13-000128#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VII ASSOCIATES LP; TREU JESSE I; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; Halak Brian K","owner_display_name":"DP VII ASSOCIATES LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":234.0,"shares_display":"234","price_per_share":5.38,"price_display":"5.38","price_state":"stated","total_value":1258.92,"total_display":"1,258.92","total_whole":"1,259","shares_owned_after":44562.0,"shares_owned_after_display":"44,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-25","filed_date":"2013-01-28","scope":"insider"},{"id":5552945,"accession":"0000904454-13-000128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000128","line_url":"/filing/0000904454-13-000128#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VII ASSOCIATES LP; TREU JESSE I; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; Halak Brian K","owner_display_name":"DP VII ASSOCIATES LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":616.0,"shares_display":"616","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":3357.2,"total_display":"3,357.20","total_whole":"3,357","shares_owned_after":44796.0,"shares_owned_after_display":"44,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-24","filed_date":"2013-01-28","scope":"insider"},{"id":4217014,"accession":"0000904454-13-000082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000082","line_url":"/filing/0000904454-13-000082#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Halak Brian K; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; DP VII ASSOCIATES LP; BLAIR JAMES C; TREU JESSE I","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430.0,"shares_display":"430","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":2197.3,"total_display":"2,197.30","total_whole":"2,197","shares_owned_after":45412.0,"shares_owned_after_display":"45,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-23","filed_date":"2013-01-24","scope":"insider"},{"id":4217010,"accession":"0000904454-13-000082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000082","line_url":"/filing/0000904454-13-000082#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Halak Brian K; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; DP VII ASSOCIATES LP; BLAIR JAMES C; TREU JESSE I","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":254.0,"shares_display":"254","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":1275.08,"total_display":"1,275.08","total_whole":"1,275","shares_owned_after":45842.0,"shares_owned_after_display":"45,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-22","filed_date":"2013-01-24","scope":"insider"},{"id":5048489,"accession":"0000904454-13-000062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000062","line_url":"/filing/0000904454-13-000062#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; SCHOEMAKER KATHLEEN K; DP VII ASSOCIATES LP; DOVEY BRIAN H; BLAIR JAMES C; Halak Brian K","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":324.0,"shares_display":"324","price_per_share":5.19,"price_display":"5.19","price_state":"stated","total_value":1681.56,"total_display":"1,681.56","total_whole":"1,682","shares_owned_after":46096.0,"shares_owned_after_display":"46,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-18","filed_date":"2013-01-22","scope":"insider"},{"id":5048485,"accession":"0000904454-13-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000062","line_url":"/filing/0000904454-13-000062#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; SCHOEMAKER KATHLEEN K; DP VII ASSOCIATES LP; DOVEY BRIAN H; BLAIR JAMES C; Halak Brian K","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":214.0,"shares_display":"214","price_per_share":5.35,"price_display":"5.35","price_state":"stated","total_value":1144.9,"total_display":"1,144.90","total_whole":"1,145","shares_owned_after":46420.0,"shares_owned_after_display":"46,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-17","filed_date":"2013-01-22","scope":"insider"},{"id":9097688,"accession":"0000904454-11-000679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-11-000679","line_url":"/filing/0000904454-11-000679#line-1","is_derivative":false,"issuer_cik":"0001372932","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001372932","owner_cik":"0001372932","owner_name":"DP VII ASSOCIATES LP","owner_display_name":"DP VII ASSOCIATES LP","owner_url":"/insider/0001372932","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7882.0,"shares_display":"7,882","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":11428.9,"total_display":"11,428.90","total_whole":"11,429","shares_owned_after":50643.0,"shares_owned_after_display":"50,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-22","filed_date":"2011-12-22","scope":"insider"}],"collapsed":true,"next_cursor":"2011-12-22|9097688","ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":21,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001403708","name":"Evoke Pharma Inc","url":"/issuer/0001403708","role":"Ten percent owner","n_filings":7,"first_seen":"2015-04-16","last_seen":"2016-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Ten percent owner","n_filings":1,"first_seen":"2013-07-02","last_seen":"2013-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Ten percent owner","n_filings":3,"first_seen":"2011-11-21","last_seen":"2013-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Ten percent owner","n_filings":17,"first_seen":"2013-01-22","last_seen":"2013-03-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001382911","name":"Orexigen Therapeutics, Inc.","url":"/issuer/0001382911","role":"Ten percent owner","n_filings":12,"first_seen":"2008-12-11","last_seen":"2011-12-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001375151","name":"ZOGENIX, INC.","url":"/issuer/0001375151","role":"Ten percent owner","n_filings":2,"first_seen":"2010-12-01","last_seen":"2011-09-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001372932","retrieved_at":"2026-08-25T14:05:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}